BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 6992531)

  • 21. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin).
    Aiken JW; Shebuski RJ
    Prostaglandins; 1980 Apr; 19(4):629-43. PubMed ID: 6992235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The general pharmacology of prostacyclin (pgi2, pgx): a new prostaglandin especially activity on the cardiovascular system.
    Weeks JR
    Pol J Pharmacol Pharm; 1978; 30(2-3):215-21. PubMed ID: 97642
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin II-induced renal prostacyclin release suppresses platelet aggregation in the anesthetized dog.
    Shebuski RJ; Aiken JW
    Adv Prostaglandin Thromboxane Res; 1980; 7():1149-52. PubMed ID: 6989184
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and structure-activity relationship of novel stable prostacyclin analogs.
    Aristoff PA; Harrison AW; Aiken JW; Gorman RR; Pike JE
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():267-74. PubMed ID: 6221535
    [No Abstract]   [Full Text] [Related]  

  • 26. Antithrombotic and vasodilating effects of OP-41483, a prostacyclin derivative.
    Kinjo O; Kusaba A; Uesato T; Shiroma H; Koja K; Kina M; Kuniyoshi Y; Iha K; Shiohira T; Kawabata T
    Int Angiol; 1987; 6(3):279-85. PubMed ID: 3329206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new stable prostacyclin mimic, 7-oxoprostaglandin I2.
    Kovács G; Simonidesz V; Tömösközi I; Körmöczy P; Székely I; Papp-Behr A; Stadler I; Szekeres L; Papp G
    J Med Chem; 1982 Feb; 25(2):105-7. PubMed ID: 7035669
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis of stable prostacyclin analogs.
    Bartmann W; Beck G; Knolle J; Rupp RH; Schölkens BA; Weithmann U
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():287-92. PubMed ID: 6221539
    [No Abstract]   [Full Text] [Related]  

  • 29. Syntheses of 13-oxa- and 13-thiaprostacyclins: biologically potent analogs of prostacyclin.
    Novák L; Aszódi J; Stadler I; Körmöczy P; Simonidesz V; Szántay C
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():275-80. PubMed ID: 6221537
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog.
    Imai S; Matsubara I
    Artery; 1980; 8(1):63-72. PubMed ID: 7000043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of PGI2 and PGI2 analogues with increased stability on platelet cAMP content and aggregation.
    Blaskó G; Nemesánszky E; Szabó G; Stadler I; Pálos LA
    Thromb Res; 1980 Mar; 17(5):673-81. PubMed ID: 6247777
    [No Abstract]   [Full Text] [Related]  

  • 32. Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma.
    Dembinska-Kiec A; Rücker W; Schönhöfer PS; Gandolfi C
    Thromb Haemost; 1979 Dec; 42(4):1340-3. PubMed ID: 232318
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of prostacyclin on blood circulatory indices in the rat].
    Markov KhM; Pinelis VG
    Patol Fiziol Eksp Ter; 1982; (2):35-8. PubMed ID: 7045784
    [No Abstract]   [Full Text] [Related]  

  • 34. Vasodilation and inhibition of platelet aggregation by prostacyclins with modified omega-side chain.
    Schölkens BA; Bartmann W; Beck G; Lerch U; Konz E; Weithmann U
    Prostaglandins Med; 1979 Jul; 3(1):7-22. PubMed ID: 399529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
    Bussolino F; Camussi G
    Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antiaggregation activity of various synthetic prostaglandins].
    Kudriashov SA; Geling NG; Mel'nikova VI; Pivnitskiĭ KK
    Biull Eksp Biol Med; 1982 Nov; 94(11):7-9. PubMed ID: 6758877
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effect of fluorinated prostaglandins on platelet aggregation].
    Lakin KM; Makarov VA; Kovalev SG; Petrukhina GN; Serkov IV; Golovanova NK; Bezuglov VV
    Eksp Klin Farmakol; 1994; 57(2):39-41. PubMed ID: 8205047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of platelet aggregation and reversal of vasopressin-induced ECG changes by a carboprostacyclin analogue, ONO 41483, in primates.
    Adaikan PG; Kottegoda SR; Lau LC; Tai MY; Karim SM
    Prostaglandins Leukot Med; 1982 Sep; 9(3):307-20. PubMed ID: 6752959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antiplatelet activity of immobilized prostacyclin.
    Ebert CD; Lee ES; Kim SW
    J Biomed Mater Res; 1982 Sep; 16(5):629-38. PubMed ID: 6752148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of prostacyclin, a stable analogue, 6 beta-PGI1 and 6-oxo-PGF1 alpha on canine isolated parietal cells [proceedings].
    Soll AH; Whittle BJ
    Br J Pharmacol; 1979 May; 66(1):97P-98P. PubMed ID: 378311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.